Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Vitale

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Acta Bio-Medica : Atenei Parmensis|January 9, 2015
A hand-made supplementary food for malnourished childrenMaurizio Vanelli, Raffaele Virdis, Sandro Contini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell ResponsesAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Journal for Immunotherapy of Cancer|November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletionAnna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications|June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockadeAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Cancer Research|July 22, 2020
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite InstabilityGuido Leoni, Anna Morena D'Alise, Gabriella Cotugno, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Acta Bio-Medica : Atenei Parmensis|January 9, 2015
A hand-made supplementary food for malnourished childrenMaurizio Vanelli, Raffaele Virdis, Sandro Contini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell ResponsesAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Journal for Immunotherapy of Cancer|November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletionAnna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications|June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockadeAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Cancer Research|July 22, 2020
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite InstabilityGuido Leoni, Anna Morena D'Alise, Gabriella Cotugno, et al.
Pageof 2